Jersey City, NJ, United States of America

Iyassu Sebhat

This inventor holds 38 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Kallyope, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iyassu Sebhat. Retrieved from https://idiyas.com/inventor/iyassu-sebhat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 16)

% Patents Active = 65.8

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 18 (Patent Applications = 29)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 121(Granted Patents)

Location History:

Hoboken, NJ (US) (2002)
New York, NY (US) (2004 - 2008)
Jersey City, NJ (US) (2010 - 2023)

Company Filing History:

25 out of 2,405

Merck Sharp + Dohme Corp.

Albany Molecular Research, Inc.

patents

5. 3 out of 64

Metabasis Therapeutics, Inc.

Merck Shapr & Dohme Corp.

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

AMPK Activators

GPR40 Agonists

GPR119 Agonists

Anti-Diabetic Agents

Benzimidazole Derivatives

Melanocortin Receptor Agonists

Prolylcarboxypeptidase Inhibitors

Angiotensin II Antagonists

Cyclic Benzimidazole Derivatives

Substituted Imidazoles

Chromane Derivatives

Tetrahydronaphthyridine Derivatives

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264171 - GPR40 agonists (2025-04-01),

2. 11851429 - AMPK activators (2023-12-26),

3. 11512065 - GPR119 agonists (2022-11-29),

4. 11407768 - AMPK activators (2022-08-09),

5. 11279702 - AMPK activators (2022-03-22),

6. 10806724 - Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2020-10-20),

7. 10335399 - Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use (2019-07-02),

8. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2018-09-11),

9. 9868733 - Azabenzimidazole tetrahydrofuran derivatives (2018-01-16),

10. 9650375 - Indole derivatives useful as anti-diabetic agents (2017-05-16),

11. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives (2017-01-31),

12. 9540364 - Benzimidazole tetrahydrofuran derivatives (2017-01-10),

13. 9527839 - Benzimidazole tetrahydropyran derivatives (2016-12-27),

14. 9382243 - Azabenzimidazole tetrahydropyran derivatives (2016-07-05),

15. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives (2016-03-22),

Title: The Innovative Mind of Iyassu Sebhat

Introduction: Iyassu Sebhat, a talented inventor based in Jersey City, NJ, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sebhat's latest patents include cutting-edge solutions in the realm of artificial intelligence, renewable energy, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Sebhat has established himself as a visionary in the tech industry, with a strong focus on creating solutions that positively impact society.

Collaborations: Throughout his career, Sebhat has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life and make a lasting impact on the world.

Conclusion: Iyassu Sebhat's dedication to innovation and his passion for creating a better future through technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.